Purchase Order 19GG8022P0661
Award Date 7/15/22
Potential Completion Date 11/30/22
Potential Value $91K
Funding Federal Agency
Contracting Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
- Not listed
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Georgia
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Economy Act
National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a firm fixed price purchase order contract awarded by the Centers for Disease Control and Prevention (CDC) to Illumina, Inc. for a MiSeq System, sequencing instrument and associated services. The contract has a ceiling value of $97,020.00 and was awarded on April 13, 2022, with a completion date of July 1, 2022. This contract was not set aside for a specific business type. Illumina is a for-profit manufacturer of genomic sequencing and analysis products, and has experience providing...
- This is a $94,050.00 firm fixed price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Illumina, Inc., a manufacturer of sequencing and analysis instruments and reagents. The award is for an Illumina MiSeq sequencing system and does not have a set-aside designation. Illumina has a history of providing sequencing equipment and services to support research and diagnostics across various federal agencies, including the National Institutes of Health, Department of...
- This is a firm fixed price purchase order contract awarded by the Centers for Disease Control and Prevention (CDC) to Illumina, Inc., a manufacturer of sequencing and array-based solutions for genetic and genomic analysis. The contract is for the provision of a MiSeq system, a DNA sequencing instrument, at a ceiling value of $95,931.00. The contract does not have a set-aside designation. Illumina has previously been awarded other prime federal contracts and sub-grants to provide sequencing...
- This is a firm fixed price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Illumina, Inc., a for-profit manufacturer of genetic sequencing instruments and reagents. The contract is for the provision of an Illumina MiSeq genomic sequencing system, with a ceiling value of $135,435.37 and a performance period ending on November 30, 2015. The order does not have a set-aside designation. Illumina has previously received prime federal contract awards from agencies...
- This firm fixed price purchase order contract was awarded by the Centers for Disease Control and Prevention (CDC) to Illumina, Inc. for the provision of MiSeq Sequencing Kits. The total ceiling value of the contract is $184,230.65, with a completion date of October 10, 2024. The contract is not set-aside. The MiSeq Sequencing Kits are being procured to support the CDC's surveillance, outbreak, and research activities for strain characterization of streptococcal pathogens. Obtaining...
- This is a firm fixed price purchase order awarded by the U.S. Centers for Disease Control and Prevention (CDC) to Illumina, Inc., a manufacturer of genetic sequencing instruments and reagents, for a MiSeq System. The $131,966.00 contract has a period of performance ending on July 31, 2016. Illumina has provided sequencing systems and services to various federal agencies in the past, including the National Institutes of Health, Department of Agriculture, and Department of Veterans Affairs, to...
- This is a firm fixed price purchase order contract awarded by the Centers for Disease Control and Prevention (CDC) to Illumina, Inc., a manufacturer of sequencing and genomic analysis instruments and reagents. The contract has a ceiling value of $77,888.22 and will support the delivery of HI-/MI-SEQ KITS with a period of performance ending on September 30, 2016. The contract does not have a set-aside designation. Illumina has previously received prime federal contract awards from agencies such...
- This is a firm fixed price contract awarded by the Centers for Disease Control and Prevention (CDC) to Illumina, Inc., a manufacturer of genetic sequencing equipment and reagents. The contract is for the provision of a MiSeq sequencing system, valued at $97,020.00. The contract has an ultimate completion date of October 19, 2020. Illumina has previously been awarded federal contracts and grants by agencies such as the National Institutes of Health, USDA, and VA to provide a range of sequencing...
- This is a firm fixed-price purchase order awarded by the Centers for Disease Control and Prevention (CDC) Pittsburgh office to Illumina, Inc., a manufacturer and provider of sequencing and array-based solutions for genetic and genomic analysis. The $19,542.00 award is for 2023 MiSeq Silver support and system health check services. The contract has a completion date of September 24, 2024 and was awarded on September 28, 2023. There was no set-aside designation used for this procurement....
- This is a firm fixed price purchase order contract awarded by the Centers for Disease Control and Prevention (CDC) to Illumina, Inc., a manufacturer of sequencing and analytical instruments and reagents. The contract is for maintenance services on an unspecified range of Illumina's sequencing systems, including NextSeq, NovaSeq, MiSeq, and iSeq models. The contract has a ceiling value of $149,442.60 and an ultimate completion date of September 25, 2017. The contract does not have a set-aside...